| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.817 | 0.004 | 0.907 | Cholesterol antagonist | 0.907 0.002 DBMET01165 0.875 0.003 DBMET02785 0.853 0.003 DBMET02786 | DBMET01165 | |
| 0.76 | 0.004 | 0.76 | Hypolipemic | 0.711 0.005 DBMET01165 0.741 0.004 DBMET02785 0.749 0.004 DBMET02786 | ||
| 0.653 | 0.012 | 0.694 | Aldehyde oxidase inhibitor | 0.499 0.033 DBMET02785 0.694 0.009 DBMET02786 | DBMET02786 | |
| 0.645 | 0.02 | 0.772 | Cyclophilin D inhibitor | 0.772 0.008 DBMET01165 0.681 0.016 DBMET02785 0.656 0.019 DBMET02786 | DBMET01165 | |
| 0.628 | 0.013 | 0.69 | Vasodilator, peripheral | 0.69 0.007 DBMET01165 0.649 0.01 DBMET02785 0.635 0.012 DBMET02786 | DBMET01165 | |
| 0.606 | 0.002 | 0.624 | Farnesoid X receptor antagonist | 0.393 0.004 DBMET01165 0.526 0.003 DBMET02785 0.624 0.002 DBMET02786 | DBMET02786 | |
| 0.568 | 0.016 | 0.568 | 5 Hydroxytryptamine release inhibitor | 0.516 0.028 DBMET01165 0.435 0.058 DBMET02785 0.529 0.024 DBMET02786 | ||
| 0.537 | 0.012 | 0.647 | Hypoglycemic | 0.647 0.006 DBMET01165 0.56 0.01 DBMET02785 0.544 0.012 DBMET02786 | DBMET01165 | |
| 0.531 | 0.012 | 0.789 | Vasodilator, coronary | 0.789 0.004 DBMET01165 0.561 0.01 DBMET02785 0.54 0.011 DBMET02786 | DBMET01165 | |
| 0.539 | 0.024 | 0.743 | Antithrombotic | 0.743 0.006 DBMET01165 0.579 0.018 DBMET02785 0.532 0.025 DBMET02786 | DBMET01165 | |
| 0.508 | 0.036 | 0.519 | Antiobesity | 0.331 0.097 DBMET01165 0.519 0.033 DBMET02785 0.493 0.039 DBMET02786 | DBMET02785 | |
| 0.468 | 0.002 | 0.468 | Peroxisome proliferator-activated receptor alpha agonist | 0.115 0.01 DBMET01165 0.379 0.003 DBMET02785 0.335 0.003 DBMET02786 | ||
| 0.461 | 0.003 | 0.515 | Leukotriene B4 receptor 1 antagonist | 0.084 0.004 DBMET01165 0.391 0.003 DBMET02785 0.515 0.002 DBMET02786 | DBMET02786 | |
| 0.503 | 0.059 | 0.801 | Caspase 9 stimulant | 0.801 0.011 DBMET01165 0.576 0.04 DBMET02785 0.542 0.047 DBMET02786 | DBMET01165 | |
| 0.449 | 0.027 | 0.537 | Lipoxygenase inhibitor | 0.464 0.024 DBMET02785 0.537 0.014 DBMET02786 | DBMET02786 | |
| 0.468 | 0.049 | 0.865 | Transcription factor NF kappa B inhibitor | 0.865 0.009 DBMET01165 0.512 0.043 DBMET02785 0.567 0.035 DBMET02786 | DBMET01165 | |
| 0.461 | 0.045 | 0.51 | Histamine release inhibitor | 0.51 0.026 DBMET01165 0.396 0.078 DBMET02785 0.485 0.034 DBMET02786 | DBMET01165 | |
| 0.411 | 0.025 | 0.411 | Platelet antagonist | 0.408 0.025 DBMET01165 0.398 0.027 DBMET02785 0.397 0.028 DBMET02786 | ||
| 0.394 | 0.01 | 0.475 | Lipid peroxidase inhibitor | 0.475 0.006 DBMET01165 0.39 0.01 DBMET02785 0.475 0.006 DBMET02786 | DBMET02786 | |
| 0.395 | 0.024 | 0.53 | Vasodilator | 0.53 0.01 DBMET01165 0.401 0.023 DBMET02785 0.415 0.021 DBMET02786 | DBMET01165 | |
| 0.361 | 0.006 | 0.389 | Cholesterol synthesis inhibitor | 0.29 0.013 DBMET01165 0.323 0.009 DBMET02785 0.389 0.005 DBMET02786 | DBMET02786 | |
| 0.345 | 0.005 | 0.345 | ABCA1 expression enhancer | 0.133 0.023 DBMET01165 0.289 0.005 DBMET02785 0.296 0.005 DBMET02786 | ||
| 0.34 | 0.013 | 0.34 | Gastrin inhibitor | 0.273 0.055 DBMET01165 0.306 0.029 DBMET02785 0.304 0.03 DBMET02786 | ||
| 0.341 | 0.021 | 0.461 | Non-steroidal antiinflammatory agent | 0.461 0.009 DBMET01165 0.33 0.022 DBMET02785 0.378 0.016 DBMET02786 | DBMET01165 | |
| 0.366 | 0.048 | 0.404 | Spasmolytic | 0.404 0.039 DBMET01165 0.386 0.043 DBMET02785 0.395 0.041 DBMET02786 | DBMET01165 | |
| 0.359 | 0.044 | 0.359 | Calcium channel activator | 0.35 0.05 DBMET02785 0.359 0.044 DBMET02786 | ||
| 0.351 | 0.039 | 0.379 | Sodium/bile acid cotransporter inhibitor | 0.257 0.12 DBMET01165 0.337 0.048 DBMET02785 0.379 0.024 DBMET02786 | DBMET02786 | |
| 0.296 | 0.002 | 0.296 | Peroxisome proliferator-activated receptor delta agonist | 0.033 0.024 DBMET01165 0.291 0.002 DBMET02785 0.204 0.003 DBMET02786 | ||
| 0.296 | 0.005 | 0.296 | Peroxisome proliferator-activated receptor gamma agonist | 0.114 0.022 DBMET01165 0.247 0.005 DBMET02785 0.271 0.005 DBMET02786 | ||
| 0.339 | 0.049 | 0.635 | Antioxidant | 0.635 0.009 DBMET01165 0.359 0.044 DBMET02785 0.446 0.027 DBMET02786 | DBMET01165 | |
| 0.289 | 0.004 | 0.354 | Leukotriene antagonist | 0.178 0.007 DBMET01165 0.324 0.003 DBMET02785 0.354 0.003 DBMET02786 | DBMET02786 | |
| 0.31 | 0.028 | 0.342 | Tyrosine 3 hydroxylase inhibitor | 0.254 0.064 DBMET02785 0.342 0.018 DBMET02786 | DBMET02786 | |
| 0.297 | 0.017 | 0.432 | Protein kinase stimulant | 0.432 0.006 DBMET01165 0.38 0.009 DBMET02785 0.308 0.016 DBMET02786 | DBMET01165 | |
| 0.289 | 0.013 | 0.335 | Succinate dehydrogenase inhibitor | 0.235 0.028 DBMET02785 0.335 0.007 DBMET02786 | DBMET02786 | |
| 0.279 | 0.003 | 0.279 | Peroxisome proliferator-activated receptor gamma antagonist | 0.075 0.041 DBMET01165 0.239 0.004 DBMET02785 0.231 0.004 DBMET02786 | ||
| 0.288 | 0.014 | 0.288 | Anesthetic local | 0.283 0.014 DBMET02785 0.279 0.015 DBMET02786 | ||
| 0.294 | 0.02 | 0.316 | Neurotrophic factor enhancer | 0.265 0.031 DBMET01165 0.309 0.016 DBMET02785 0.316 0.014 DBMET02786 | DBMET02786 | |
| 0.287 | 0.015 | 0.302 | Phospholipase A2 inhibitor | 0.272 0.018 DBMET01165 0.274 0.018 DBMET02785 0.302 0.013 DBMET02786 | DBMET02786 | |
| 0.288 | 0.017 | 0.47 | Hemostatic | 0.47 0.005 DBMET01165 0.352 0.011 DBMET02785 0.264 0.02 DBMET02786 | DBMET01165 | |
| 0.286 | 0.019 | 0.289 | Insulin sensitizer | 0.216 0.058 DBMET01165 0.289 0.018 DBMET02785 0.283 0.02 DBMET02786 | DBMET02785 | |
| 0.295 | 0.047 | 0.295 | Ca(v)3.3 blocker | 0.262 0.083 DBMET02785 0.269 0.074 DBMET02786 | ||
| 0.264 | 0.016 | 0.292 | Aldehyde dehydrogenase inhibitor | 0.169 0.038 DBMET01165 0.292 0.013 DBMET02785 0.252 0.018 DBMET02786 | DBMET02785 | |
| 0.265 | 0.02 | 0.336 | Alpha-N-acetylglucosaminidase inhibitor | 0.336 0.013 DBMET01165 0.278 0.019 DBMET02785 0.253 0.022 DBMET02786 | DBMET01165 | |
| 0.247 | 0.003 | 0.343 | Leukotriene B4 antagonist | 0.186 0.004 DBMET01165 0.275 0.003 DBMET02785 0.343 0.002 DBMET02786 | DBMET02786 | |
| 0.289 | 0.046 | 0.289 | Psychostimulant | 0.214 0.073 DBMET01165 0.256 0.056 DBMET02785 0.251 0.058 DBMET02786 | ||
| 0.283 | 0.04 | 0.283 | Platelet aggregation inhibitor | 0.236 0.059 DBMET02785 0.237 0.058 DBMET02786 | ||
| 0.251 | 0.028 | 0.39 | Interferon gamma antagonist | 0.39 0.011 DBMET01165 0.213 0.037 DBMET02785 0.278 0.023 DBMET02786 | DBMET01165 | |
| 0.225 | 0.004 | 0.225 | Peroxisome proliferator-activated receptor delta antagonist | 0.033 0.023 DBMET01165 0.185 0.004 DBMET02785 0.191 0.004 DBMET02786 | ||
| 0.255 | 0.04 | 0.289 | P-glycoprotein inhibitor | 0.289 0.031 DBMET01165 0.228 0.05 DBMET02785 0.251 0.041 DBMET02786 | DBMET01165 | |
| 0.35 | 0.139 | 0.659 | Apoptosis agonist | 0.659 0.037 DBMET01165 0.384 0.122 DBMET02785 0.436 0.097 DBMET02786 | DBMET01165 | |
| 0.213 | 0.002 | 0.213 | G-protein-coupled receptor 120 agonist | 0.206 0.002 DBMET02785 0.113 0.003 DBMET02786 | ||
| 0.251 | 0.042 | 0.303 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.229 0.053 DBMET01165 0.246 0.044 DBMET02785 0.303 0.023 DBMET02786 | DBMET02786 | |
| 0.214 | 0.007 | 0.214 | Sphingosine 1-phosphate receptor 5 antagonist | 0.185 0.02 DBMET02785 0.195 0.014 DBMET02786 | ||
| 0.314 | 0.106 | 0.546 | Immunosuppressant | 0.546 0.022 DBMET01165 0.331 0.097 DBMET02785 0.325 0.1 DBMET02786 | DBMET01165 | |
| 0.225 | 0.02 | 0.269 | 5-Lipoxygenase inhibitor | 0.216 0.021 DBMET02785 0.269 0.013 DBMET02786 | DBMET02786 | |
| 0.214 | 0.009 | 0.427 | AMP-activated protein kinase stimulant | 0.427 0.004 DBMET01165 0.234 0.008 DBMET02785 0.273 0.005 DBMET02786 | DBMET01165 | |
| 0.253 | 0.049 | 0.283 | Anesthetic general | 0.261 0.046 DBMET01165 0.203 0.073 DBMET02785 0.283 0.038 DBMET02786 | DBMET02786 | |
| 0.206 | 0.003 | 0.206 | Peroxisome proliferator-activated receptor alpha antagonist | 0.17 0.003 DBMET02785 0.18 0.003 DBMET02786 | ||
| 0.216 | 0.014 | 0.392 | Cyclooxygenase 3 inhibitor | 0.392 0.004 DBMET01165 0.203 0.018 DBMET02785 0.209 0.016 DBMET02786 | DBMET01165 | |
| 0.264 | 0.066 | 0.346 | Superoxide dismutase inhibitor | 0.183 0.138 DBMET02785 0.346 0.037 DBMET02786 | DBMET02786 | |
| 0.202 | 0.005 | 0.246 | Leukotriene synthesis inhibitor | 0.246 0.005 DBMET02785 0.221 0.005 DBMET02786 | DBMET02785 | |
| 0.216 | 0.02 | 0.227 | Arachidonic acid antagonist | 0.148 0.09 DBMET01165 0.193 0.04 DBMET02785 0.227 0.013 DBMET02786 | DBMET02786 | |
| 0.196 | 0.004 | 0.196 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.152 0.004 DBMET02785 0.16 0.004 DBMET02786 | ||
| 0.227 | 0.035 | 0.427 | Amylase inhibitor | 0.427 0.008 DBMET01165 0.262 0.025 DBMET02785 0.26 0.025 DBMET02786 | DBMET01165 | |
| 0.202 | 0.011 | 0.209 | Vanilloid 1 agonist | 0.179 0.019 DBMET01165 0.206 0.01 DBMET02785 0.209 0.01 DBMET02786 | DBMET02786 | |
| 0.223 | 0.032 | 0.274 | Phospholipase C inhibitor | 0.18 0.06 DBMET01165 0.251 0.025 DBMET02785 0.274 0.021 DBMET02786 | DBMET02786 | |
| 0.241 | 0.051 | 0.315 | DNA methyltransferase I inhibitor | 0.315 0.021 DBMET01165 0.198 0.07 DBMET02785 0.277 0.035 DBMET02786 | DBMET01165 | |
| 0.193 | 0.01 | 0.193 | Sphingosine 1-phosphate receptor 2 antagonist | 0.183 0.013 DBMET02785 0.175 0.017 DBMET02786 | ||
| 0.192 | 0.01 | 0.192 | Sphingosine 1-phosphate receptor 4 antagonist | 0.189 0.011 DBMET02785 0.163 0.023 DBMET02786 | ||
| 0.254 | 0.076 | 0.375 | Interleukin agonist | 0.375 0.023 DBMET01165 0.303 0.046 DBMET02785 0.288 0.054 DBMET02786 | DBMET01165 | |
| 0.194 | 0.024 | 0.194 | Ferrochelatase inhibitor | 0.118 0.055 DBMET02785 0.145 0.04 DBMET02786 | ||
| 0.217 | 0.047 | 0.218 | Lipocortins synthesis antagonist | 0.164 0.087 DBMET01165 0.184 0.067 DBMET02785 0.218 0.046 DBMET02786 | DBMET02786 | |
| 0.258 | 0.093 | 0.554 | Immunostimulant | 0.554 0.022 DBMET01165 0.318 0.074 DBMET02785 0.319 0.073 DBMET02786 | DBMET01165 | |
| 0.18 | 0.016 | 0.182 | Gastric antisecretory | 0.093 0.075 DBMET01165 0.182 0.016 DBMET02785 0.164 0.021 DBMET02786 | DBMET02785 | |
| 0.184 | 0.023 | 0.205 | Adenylate cyclase stimulant | 0.142 0.077 DBMET01165 0.186 0.021 DBMET02785 0.205 0.012 DBMET02786 | DBMET02786 | |
| 0.165 | 0.005 | 0.165 | Acetyl-CoA transferase inhibitor | 0.1 0.013 DBMET01165 0.135 0.007 DBMET02785 0.145 0.006 DBMET02786 | ||
| 0.178 | 0.019 | 0.178 | Adenylate kinase inhibitor | 0.111 0.052 DBMET01165 0.154 0.025 DBMET02785 0.178 0.019 DBMET02786 | ||
| 0.196 | 0.038 | 0.262 | Insulin secretagoues | 0.262 0.017 DBMET01165 0.185 0.044 DBMET02785 0.166 0.059 DBMET02786 | DBMET01165 | |
| 0.157 | 0.002 | 0.167 | Leukotriene C antagonist | 0.065 0.02 DBMET01165 0.155 0.002 DBMET02785 0.167 0.002 DBMET02786 | DBMET02786 | |
| 0.174 | 0.021 | 0.209 | Mucolytic | 0.151 0.032 DBMET01165 0.204 0.013 DBMET02785 0.209 0.011 DBMET02786 | DBMET02786 | |
| 0.282 | 0.129 | 0.341 | GABA C receptor rho-3 antagonist | 0.341 0.091 DBMET02786 | DBMET02786 | |
| 0.158 | 0.007 | 0.158 | Sphingosine 1-phosphate receptor 4 agonist | 0.146 0.009 DBMET02785 0.123 0.016 DBMET02786 | ||
| 0.165 | 0.016 | 0.242 | Triose-phosphate isomerase inhibitor | 0.242 0.007 DBMET01165 0.17 0.015 DBMET02785 0.131 0.027 DBMET02786 | DBMET01165 | |
| 0.229 | 0.081 | 0.373 | Antiamyloidogenic | 0.373 0.034 DBMET01165 0.225 0.084 DBMET02785 0.335 0.042 DBMET02786 | DBMET01165 | |
| 0.148 | 0.005 | 0.149 | Thromboxane antagonist | 0.149 0.005 DBMET02785 0.13 0.006 DBMET02786 | DBMET02785 | |
| 0.171 | 0.028 | 0.315 | Expectorant | 0.315 0.008 DBMET01165 0.199 0.02 DBMET02785 0.213 0.018 DBMET02786 | DBMET01165 | |
| 0.148 | 0.008 | 0.166 | Bile acid receptor antagonist | 0.1 0.05 DBMET01165 0.135 0.011 DBMET02785 0.166 0.005 DBMET02786 | DBMET02786 | |
| 0.188 | 0.048 | 0.257 | ATPase inhibitor | 0.257 0.012 DBMET01165 0.192 0.045 DBMET02786 | DBMET01165 | |
| 0.192 | 0.054 | 0.192 | Antipruritic | 0.148 0.097 DBMET02785 0.172 0.071 DBMET02786 | ||
| 0.321 | 0.185 | 0.321 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.203 | 0.069 | 0.389 | Platelet adhesion inhibitor | 0.389 0.013 DBMET01165 0.203 0.069 DBMET02785 0.226 0.058 DBMET02786 | DBMET01165 | |
| 0.135 | 0.002 | 0.147 | Leukotriene C4 antagonist | 0.043 0.018 DBMET01165 0.133 0.002 DBMET02785 0.147 0.002 DBMET02786 | DBMET02786 | |
| 0.206 | 0.075 | 0.344 | DNA methylase inhibitor | 0.344 0.018 DBMET01165 0.184 0.09 DBMET02785 0.243 0.052 DBMET02786 | DBMET01165 | |
| 0.181 | 0.051 | 0.251 | Melanin inhibitor | 0.251 0.028 DBMET01165 0.163 0.066 DBMET02785 0.219 0.035 DBMET02786 | DBMET01165 | |
| 0.157 | 0.028 | 0.166 | Ca2+-transporting ATPase inhibitor | 0.166 0.016 DBMET01165 0.149 0.045 DBMET02785 0.162 0.021 DBMET02786 | DBMET01165 | |
| 0.156 | 0.028 | 0.189 | Photosensitizer | 0.173 0.02 DBMET01165 0.167 0.023 DBMET02785 0.189 0.015 DBMET02786 | DBMET02786 | |
| 0.133 | 0.006 | 0.134 | Estrogen-related receptor beta agonist | 0.105 0.02 DBMET02785 0.134 0.006 DBMET02786 | DBMET02786 | |
| 0.133 | 0.007 | 0.137 | Leukocyte elastase inhibitor | 0.137 0.006 DBMET02785 0.1 0.009 DBMET02786 | DBMET02785 | |
| 0.154 | 0.028 | 0.157 | TRPA1 agonist | 0.103 0.082 DBMET02785 0.157 0.027 DBMET02786 | DBMET02786 | |
| 0.128 | 0.005 | 0.128 | Thromboxane A2 antagonist | 0.128 0.005 DBMET02785 0.11 0.006 DBMET02786 | ||
| 0.125 | 0.004 | 0.125 | Retinoid X alpha receptor agonist | 0.113 0.004 DBMET02785 0.113 0.004 DBMET02786 | ||
| 0.247 | 0.126 | 0.27 | Thyroid hormone antagonist | 0.27 0.111 DBMET02786 | DBMET02786 | |
| 0.143 | 0.022 | 0.155 | Anabolic | 0.093 0.072 DBMET01165 0.143 0.022 DBMET02785 0.155 0.015 DBMET02786 | DBMET02786 | |
| 0.208 | 0.09 | 0.623 | Angiogenesis stimulant | 0.623 0.006 DBMET01165 0.257 0.067 DBMET02785 0.265 0.063 DBMET02786 | DBMET01165 | |
| 0.154 | 0.037 | 0.154 | Interleukin 1b antagonist | 0.15 0.04 DBMET02785 0.137 0.05 DBMET02786 | ||
| 0.316 | 0.2 | 0.745 | Antiinflammatory | 0.745 0.023 DBMET01165 0.404 0.137 DBMET02785 0.422 0.126 DBMET02786 | DBMET01165 | |
| 0.174 | 0.06 | 0.233 | Protein-tyrosine phosphatase inhibitor | 0.158 0.071 DBMET01165 0.187 0.052 DBMET02785 0.233 0.036 DBMET02786 | DBMET02786 | |
| 0.134 | 0.02 | 0.197 | Transcription factor NF kappa B stimulant | 0.197 0.009 DBMET01165 0.173 0.012 DBMET02785 0.131 0.021 DBMET02786 | DBMET01165 | |
| 0.14 | 0.027 | 0.177 | Uric acid excretion stimulant | 0.137 0.029 DBMET01165 0.152 0.022 DBMET02785 0.177 0.017 DBMET02786 | DBMET02786 | |
| 0.155 | 0.045 | 0.521 | Monophenol monooxygenase inhibitor | 0.521 0.007 DBMET01165 0.184 0.037 DBMET02785 0.225 0.028 DBMET02786 | DBMET01165 | |
| 0.123 | 0.016 | 0.129 | Thioredoxin reductase inhibitor | 0.129 0.014 DBMET01165 0.127 0.014 DBMET02785 0.122 0.016 DBMET02786 | DBMET01165 | |
| 0.183 | 0.077 | 0.423 | Hepatoprotectant | 0.423 0.011 DBMET01165 0.218 0.055 DBMET02785 0.212 0.058 DBMET02786 | DBMET01165 | |
| 0.221 | 0.116 | 0.265 | 5 Hydroxytryptamine uptake stimulant | 0.212 0.13 DBMET02785 0.265 0.068 DBMET02786 | DBMET02786 | |
| 0.108 | 0.003 | 0.109 | ATP citrate lysase inhibitor | 0.073 0.004 DBMET02785 0.109 0.003 DBMET02786 | DBMET02786 | |
| 0.107 | 0.004 | 0.107 | Retinoid X receptor agonist | 0.095 0.005 DBMET02785 0.099 0.005 DBMET02786 | ||
| 0.107 | 0.005 | 0.133 | Prostaglandin agonist | 0.031 0.022 DBMET01165 0.133 0.004 DBMET02785 0.097 0.005 DBMET02786 | DBMET02785 | |
| 0.116 | 0.014 | 0.138 | Glycine receptor agonist | 0.096 0.023 DBMET01165 0.094 0.024 DBMET02785 0.138 0.009 DBMET02786 | DBMET02786 | |
| 0.236 | 0.135 | 0.449 | Interleukin 2 agonist | 0.449 0.016 DBMET01165 0.332 0.054 DBMET02785 0.291 0.081 DBMET02786 | DBMET01165 | |
| 0.105 | 0.005 | 0.113 | Leukotriene D4 antagonist | 0.023 0.021 DBMET01165 0.108 0.005 DBMET02785 0.113 0.005 DBMET02786 | DBMET02786 | |
| 0.137 | 0.04 | 0.19 | Xanthine oxidase inhibitor | 0.186 0.023 DBMET01165 0.152 0.034 DBMET02785 0.19 0.022 DBMET02786 | DBMET02786 | |
| 0.237 | 0.141 | 0.452 | Apoptosis antagonist | 0.452 0.027 DBMET01165 0.291 0.091 DBMET02785 0.277 0.102 DBMET02786 | DBMET01165 | |
| 0.102 | 0.006 | 0.102 | Thromboxane synthase inhibitor | 0.091 0.008 DBMET02785 0.09 0.008 DBMET02786 | ||
| 0.13 | 0.034 | 0.15 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.121 0.039 DBMET01165 0.15 0.027 DBMET02785 0.097 0.057 DBMET02786 | DBMET02785 | |
| 0.126 | 0.032 | 0.126 | Catalase inhibitor | 0.109 0.036 DBMET02785 0.112 0.035 DBMET02786 | ||
| 0.155 | 0.06 | 0.173 | Mannose-6-phosphate isomerase inhibitor | 0.173 0.047 DBMET01165 0.137 0.078 DBMET02785 0.166 0.052 DBMET02786 | DBMET01165 | |
| 0.207 | 0.113 | 0.324 | DNA synthesis inhibitor | 0.324 0.036 DBMET01165 0.231 0.082 DBMET02785 0.231 0.082 DBMET02786 | DBMET01165 | |
| 0.118 | 0.026 | 0.182 | Phosphofructokinase-1 inhibitor | 0.182 0.013 DBMET01165 0.121 0.025 DBMET02785 0.162 0.016 DBMET02786 | DBMET01165 | |
| 0.196 | 0.105 | 0.216 | RNA-directed DNA polymerase inhibitor | 0.166 0.16 DBMET01165 0.187 0.121 DBMET02785 0.216 0.078 DBMET02786 | DBMET02786 | |
| 0.127 | 0.036 | 0.167 | HIV-1 integrase (Overall Integration) inhibitor | 0.167 0.02 DBMET02785 0.146 0.027 DBMET02786 | DBMET02785 | |
| 0.146 | 0.055 | 0.173 | Toll-Like receptor 2 antagonist | 0.173 0.038 DBMET02785 0.156 0.048 DBMET02786 | DBMET02785 | |
| 0.096 | 0.006 | 0.107 | Sphingosine 1-phosphate receptor agonist | 0.107 0.005 DBMET02785 0.073 0.01 DBMET02786 | DBMET02785 | |
| 0.192 | 0.102 | 0.207 | Nitric-oxide synthase stimulant | 0.18 0.128 DBMET01165 0.207 0.077 DBMET02785 0.199 0.09 DBMET02786 | DBMET02785 | |
| 0.171 | 0.081 | 0.41 | Nitric oxide antagonist | 0.41 0.024 DBMET01165 0.202 0.066 DBMET02785 0.225 0.059 DBMET02786 | DBMET01165 | |
| 0.094 | 0.004 | 0.094 | Lysophosphatidic acid 2 receptor antagonist | 0.042 0.011 DBMET02785 0.059 0.007 DBMET02786 | ||
| 0.097 | 0.008 | 0.097 | Diacylglycerol O-acyltransferase inhibitor | 0.075 0.016 DBMET02785 0.076 0.016 DBMET02786 | ||
| 0.106 | 0.018 | 0.112 | Sphingosine 1-phosphate receptor antagonist | 0.112 0.015 DBMET02785 0.092 0.028 DBMET02786 | DBMET02785 | |
| 0.092 | 0.005 | 0.097 | Sphingosine 1-phosphate receptor 1 agonist | 0.097 0.005 DBMET02785 0.073 0.008 DBMET02786 | DBMET02785 | |
| 0.096 | 0.01 | 0.102 | Nitric oxide donor | 0.102 0.008 DBMET01165 0.094 0.012 DBMET02785 0.095 0.011 DBMET02786 | DBMET01165 | |
| 0.09 | 0.01 | 0.105 | Potassium channel Kv1.3 blocker | 0.076 0.013 DBMET02785 0.105 0.007 DBMET02786 | DBMET02786 | |
| 0.215 | 0.135 | 0.27 | Hypoxia-inducible factor 1 alpha inhibitor | 0.206 0.145 DBMET01165 0.21 0.14 DBMET02785 0.27 0.083 DBMET02786 | DBMET02786 | |
| 0.091 | 0.011 | 0.107 | Sphingosine 1-phosphate receptor 1 antagonist | 0.107 0.008 DBMET02785 0.078 0.015 DBMET02786 | DBMET02785 | |
| 0.106 | 0.027 | 0.161 | Keratolytic | 0.123 0.021 DBMET02785 0.161 0.013 DBMET02786 | DBMET02786 | |
| 0.083 | 0.004 | 0.083 | Free fatty acid receptor 1 antagonist | 0.078 0.004 DBMET02785 0.056 0.007 DBMET02786 | ||
| 0.111 | 0.033 | 0.126 | Ornithine decarboxylase inhibitor | 0.116 0.028 DBMET02785 0.126 0.022 DBMET02786 | DBMET02786 | |
| 0.159 | 0.081 | 0.161 | Neurotensin receptor agonist | 0.161 0.078 DBMET02786 | DBMET02786 | |
| 0.114 | 0.038 | 0.114 | Calcium antagonist | 0.085 0.059 DBMET02785 0.081 0.063 DBMET02786 | ||
| 0.217 | 0.141 | 0.235 | Thyroid hormone beta antagonist | 0.235 0.128 DBMET02786 | DBMET02786 | |
| 0.078 | 0.003 | 0.091 | Glutamate (mGluR3) agonist | 0.044 0.007 DBMET01165 0.065 0.003 DBMET02785 0.091 0.002 DBMET02786 | DBMET02786 | |
| 0.094 | 0.019 | 0.104 | Beta adrenoreceptor antagonist | 0.091 0.02 DBMET02785 0.104 0.015 DBMET02786 | DBMET02786 | |
| 0.127 | 0.053 | 0.196 | Microtubule formation inhibitor | 0.196 0.021 DBMET01165 0.118 0.063 DBMET02785 0.127 0.054 DBMET02786 | DBMET01165 | |
| 0.105 | 0.033 | 0.117 | ATPase (Vacuolar H+) inhibitor | 0.117 0.022 DBMET01165 0.089 0.058 DBMET02785 0.105 0.034 DBMET02786 | DBMET01165 | |
| 0.091 | 0.019 | 0.109 | Prostaglandin antagonist | 0.109 0.015 DBMET02785 0.061 0.031 DBMET02786 | DBMET02785 | |
| 0.12 | 0.049 | 0.127 | GABA C receptor agonist | 0.127 0.045 DBMET02786 | DBMET02786 | |
| 0.117 | 0.047 | 0.176 | Toll-Like receptor 4 antagonist | 0.176 0.01 DBMET01165 0.125 0.039 DBMET02785 0.13 0.035 DBMET02786 | DBMET01165 | |
| 0.08 | 0.009 | 0.08 | Lysophosphatidic acid 3 receptor antagonist | 0.075 0.012 DBMET02785 0.066 0.018 DBMET02786 | ||
| 0.102 | 0.031 | 0.109 | Vanilloid agonist | 0.083 0.062 DBMET01165 0.104 0.029 DBMET02785 0.109 0.025 DBMET02786 | DBMET02786 | |
| 0.127 | 0.058 | 0.174 | Protein-tyrosine phosphatase 1B inhibitor | 0.128 0.058 DBMET01165 0.139 0.05 DBMET02785 0.174 0.037 DBMET02786 | DBMET02786 | |
| 0.082 | 0.013 | 0.082 | Aconitate hydratase inhibitor | 0.059 0.027 DBMET02785 0.066 0.021 DBMET02786 | ||
| 0.121 | 0.052 | 0.121 | Aminopeptidase B inhibitor | 0.104 0.062 DBMET02786 | ||
| 0.262 | 0.193 | 0.38 | Calcium channel L-type activator | 0.38 0.095 DBMET02785 0.275 0.18 DBMET02786 | DBMET02785 | |
| 0.116 | 0.047 | 0.143 | Carbonic anhydrase III inhibitor | 0.139 0.033 DBMET02785 0.143 0.031 DBMET02786 | DBMET02786 | |
| 0.087 | 0.02 | 0.087 | Acyl-CoA dehydrogenase inhibitor | 0.071 0.026 DBMET02785 0.083 0.021 DBMET02786 | ||
| 0.069 | 0.003 | 0.069 | Lysophosphatidic acid 1 receptor antagonist | 0.059 0.003 DBMET02785 0.045 0.004 DBMET02786 | ||
| 0.133 | 0.068 | 0.156 | Cyclooxygenase 1 inhibitor | 0.126 0.075 DBMET02785 0.156 0.053 DBMET02786 | DBMET02786 | |
| 0.115 | 0.051 | 0.149 | DOPA decarboxylase inhibitor | 0.095 0.087 DBMET02785 0.149 0.022 DBMET02786 | DBMET02786 | |
| 0.077 | 0.013 | 0.077 | 5-Alpha-reductase inhibitor | 0.061 0.015 DBMET02785 0.067 0.014 DBMET02786 | ||
| 0.068 | 0.004 | 0.068 | Retinoid X receptor antagonist | 0.058 0.007 DBMET02785 0.067 0.004 DBMET02786 | ||
| 0.086 | 0.024 | 0.1 | Prostaglandin EP2 antagonist | 0.055 0.046 DBMET01165 0.1 0.019 DBMET02785 0.078 0.028 DBMET02786 | DBMET02785 | |
| 0.098 | 0.036 | 0.124 | Macrophage migration inhibitory factor inhibitor | 0.084 0.046 DBMET02785 0.124 0.024 DBMET02786 | DBMET02786 | |
| 0.084 | 0.022 | 0.114 | Xanthine dehydrogenase inhibitor | 0.095 0.017 DBMET02785 0.114 0.012 DBMET02786 | DBMET02786 | |
| 0.066 | 0.007 | 0.066 | Guanylate cyclase inhibitor | 0.062 0.01 DBMET01165 0.066 0.007 DBMET02785 0.055 0.016 DBMET02786 | ||
| 0.093 | 0.034 | 0.106 | Glutamate decarboxylase inhibitor | 0.065 0.061 DBMET02785 0.106 0.027 DBMET02786 | DBMET02786 | |
| 0.176 | 0.118 | 0.51 | Free radical scavenger | 0.51 0.015 DBMET01165 0.178 0.116 DBMET02785 0.288 0.055 DBMET02786 | DBMET01165 | |
| 0.063 | 0.004 | 0.08 | Prostaglandin EP2 agonist | 0.042 0.008 DBMET01165 0.08 0.004 DBMET02785 0.053 0.005 DBMET02786 | DBMET02785 | |
| 0.109 | 0.05 | 0.125 | Sphingomyelinase inhibitor | 0.1 0.059 DBMET01165 0.125 0.038 DBMET02785 0.094 0.066 DBMET02786 | DBMET02785 | |
| 0.096 | 0.038 | 0.172 | Porphobilinogen synthase inhibitor | 0.134 0.024 DBMET02785 0.172 0.016 DBMET02786 | DBMET02786 | |
| 0.081 | 0.023 | 0.081 | Glutamate (mGluR6) antagonist | 0.077 0.027 DBMET02785 0.077 0.028 DBMET02786 | ||
| 0.071 | 0.014 | 0.071 | Squalene epoxidase inhibitor | 0.062 0.019 DBMET01165 0.066 0.016 DBMET02785 0.067 0.015 DBMET02786 | ||
| 0.129 | 0.073 | 0.174 | Interleukin 4 antagonist | 0.163 0.039 DBMET01165 0.112 0.097 DBMET02785 0.174 0.033 DBMET02786 | DBMET02786 | |
| 0.078 | 0.022 | 0.082 | MDM2 inhibitor | 0.082 0.018 DBMET02785 0.073 0.032 DBMET02786 | DBMET02785 | |
| 0.089 | 0.033 | 0.089 | Prostaglandin-E synthase inhibitor | 0.086 0.035 DBMET02785 0.087 0.035 DBMET02786 | ||
| 0.113 | 0.058 | 0.114 | Electron transport complex I inhibitor | 0.103 0.075 DBMET02785 0.114 0.056 DBMET02786 | DBMET02786 | |
| 0.071 | 0.016 | 0.071 | Sphingosine 1-phosphate receptor 5 agonist | 0.068 0.018 DBMET02785 0.06 0.025 DBMET02786 | ||
| 0.115 | 0.062 | 0.191 | Cystathionine beta-synthase inhibitor | 0.191 0.027 DBMET02786 | DBMET02786 | |
| 0.058 | 0.004 | 0.058 | Retinoid X alpha receptor antagonist | 0.048 0.007 DBMET02785 0.056 0.004 DBMET02786 | ||
| 0.079 | 0.027 | 0.079 | Biliverdin reductase inhibitor | 0.061 0.039 DBMET02785 0.067 0.034 DBMET02786 | ||
| 0.095 | 0.042 | 0.105 | Glutathione S-transferase inhibitor | 0.081 0.059 DBMET02785 0.105 0.033 DBMET02786 | DBMET02786 | |
| 0.057 | 0.005 | 0.057 | HMG CoA reductase inhibitor | 0.057 0.005 DBMET01165 0.055 0.005 DBMET02785 0.056 0.005 DBMET02786 | ||
| 0.129 | 0.078 | 0.143 | Bone formation stimulant | 0.128 0.079 DBMET01165 0.121 0.084 DBMET02785 0.143 0.065 DBMET02786 | DBMET02786 | |
| 0.069 | 0.017 | 0.074 | Beta 2 adrenoreceptor antagonist | 0.062 0.022 DBMET02785 0.074 0.014 DBMET02786 | DBMET02786 | |
| 0.068 | 0.017 | 0.104 | Adenine nucleotide translocase inhibitor | 0.104 0.004 DBMET01165 0.062 0.025 DBMET02785 0.069 0.016 DBMET02786 | DBMET01165 | |
| 0.084 | 0.034 | 0.084 | GABA B receptor agonist | 0.084 0.034 DBMET02786 | ||
| 0.065 | 0.015 | 0.078 | Glucose-6-phosphate isomerase inhibitor | 0.078 0.009 DBMET01165 0.066 0.014 DBMET02785 0.067 0.014 DBMET02786 | DBMET01165 | |
| 0.055 | 0.005 | 0.055 | Cholesterol ester transfer protein antagonist | 0.047 0.008 DBMET02785 0.043 0.01 DBMET02786 | ||
| 0.088 | 0.038 | 0.088 | Glutamate dehydrogenase inhibitor | 0.069 0.058 DBMET02785 0.083 0.042 DBMET02786 | ||
| 0.107 | 0.058 | 0.146 | Carbonic anhydrase XV inhibitor | 0.146 0.032 DBMET02785 0.115 0.051 DBMET02786 | DBMET02785 | |
| 0.053 | 0.004 | 0.053 | Prostaglandin H2 antagonist | 0.041 0.005 DBMET02785 0.047 0.004 DBMET02786 | ||
| 0.059 | 0.01 | 0.059 | GABA uptake inhibitor | 0.049 0.016 DBMET02785 0.053 0.014 DBMET02786 | ||
| 0.072 | 0.024 | 0.073 | Sphingosine 1-phosphate receptor 3 antagonist | 0.073 0.022 DBMET02785 0.06 0.038 DBMET02786 | DBMET02785 | |
| 0.103 | 0.056 | 0.117 | Creatine kinase inhibitor | 0.117 0.043 DBMET02786 | DBMET02786 | |
| 0.077 | 0.03 | 0.081 | Carbamoyl phosphate synthetase inhibitor | 0.065 0.038 DBMET02785 0.081 0.028 DBMET02786 | DBMET02786 | |
| 0.183 | 0.136 | 0.183 | Cardiotonic | 0.164 0.159 DBMET02785 0.164 0.159 DBMET02786 | ||
| 0.087 | 0.042 | 0.112 | Interferon agonist | 0.108 0.023 DBMET01165 0.112 0.021 DBMET02785 0.086 0.044 DBMET02786 | DBMET02785 | |
| 0.221 | 0.176 | 0.246 | Toll-Like receptor 7 agonist | 0.246 0.151 DBMET02785 0.228 0.169 DBMET02786 | DBMET02785 | |
| 0.052 | 0.007 | 0.058 | Uridine phosphorylase inhibitor | 0.051 0.008 DBMET01165 0.058 0.006 DBMET02785 0.04 0.012 DBMET02786 | DBMET02785 | |
| 0.065 | 0.021 | 0.067 | Pregnane X receptor antagonist | 0.067 0.018 DBMET02786 | DBMET02786 | |
| 0.083 | 0.039 | 0.083 | Aminopeptidase I inhibitor | 0.07 0.053 DBMET02786 | ||
| 0.102 | 0.058 | 0.327 | UDP-glucose 4-epimerase inhibitor | 0.327 0.009 DBMET01165 0.109 0.052 DBMET02785 0.136 0.034 DBMET02786 | DBMET01165 | |
| 0.056 | 0.013 | 0.056 | Sphingosine 1-phosphate receptor 3 agonist | 0.049 0.017 DBMET02785 0.051 0.016 DBMET02786 | ||
| 0.132 | 0.089 | 0.215 | Peroxidase inhibitor | 0.215 0.055 DBMET02786 | DBMET02786 | |
| 0.115 | 0.072 | 0.178 | DNA polymerase I inhibitor | 0.178 0.036 DBMET01165 0.126 0.064 DBMET02785 0.148 0.05 DBMET02786 | DBMET01165 | |
| 0.044 | 0.003 | 0.052 | Vitamin D receptor agonist | 0.052 0.002 DBMET01165 0.043 0.003 DBMET02785 0.04 0.003 DBMET02786 | DBMET01165 | |
| 0.112 | 0.071 | 0.14 | Estrogen antagonist | 0.103 0.09 DBMET02785 0.14 0.028 DBMET02786 | DBMET02786 | |
| 0.219 | 0.18 | 0.253 | Toll-Like receptor agonist | 0.253 0.146 DBMET02785 0.226 0.172 DBMET02786 | DBMET02785 | |
| 0.098 | 0.06 | 0.107 | Electrolyte absorption antagonist | 0.107 0.049 DBMET02786 | DBMET02786 | |
| 0.049 | 0.011 | 0.049 | Purinergic P2X3 antagonist | 0.041 0.016 DBMET02785 0.041 0.016 DBMET02786 | ||
| 0.042 | 0.004 | 0.044 | Estrogen-related receptor gamma antagonist | 0.03 0.017 DBMET02785 0.044 0.004 DBMET02786 | DBMET02786 | |
| 0.097 | 0.059 | 0.102 | Interleukin 12 antagonist | 0.092 0.068 DBMET01165 0.102 0.051 DBMET02785 0.098 0.057 DBMET02786 | DBMET02785 | |
| 0.068 | 0.03 | 0.091 | Alcohol oxidase inhibitor | 0.091 0.02 DBMET02786 | DBMET02786 | |
| 0.066 | 0.03 | 0.067 | Beta 1 adrenoreceptor antagonist | 0.057 0.038 DBMET02785 0.067 0.029 DBMET02786 | DBMET02786 | |
| 0.07 | 0.035 | 0.09 | Interferon inducer | 0.089 0.018 DBMET01165 0.09 0.017 DBMET02785 0.069 0.036 DBMET02786 | DBMET02785 | |
| 0.04 | 0.006 | 0.04 | Prostaglandin EP4 agonist | 0.036 0.006 DBMET02785 0.021 0.009 DBMET02786 | ||
| 0.04 | 0.006 | 0.063 | Thyroid hormone agonist | 0.04 0.006 DBMET02785 0.063 0.004 DBMET02786 | DBMET02786 | |
| 0.037 | 0.003 | 0.037 | Retinoid X beta receptor antagonist | 0.027 0.005 DBMET02785 0.032 0.004 DBMET02786 | ||
| 0.038 | 0.006 | 0.052 | Prostaglandin F2 alpha agonist | 0.026 0.011 DBMET02785 0.052 0.004 DBMET02786 | DBMET02786 | |
| 0.089 | 0.057 | 0.174 | NADH dehydrogenase inhibitor | 0.174 0.013 DBMET01165 0.093 0.052 DBMET02785 0.098 0.047 DBMET02786 | DBMET01165 | |
| 0.101 | 0.069 | 0.148 | Mediator release inhibitor | 0.148 0.029 DBMET01165 0.098 0.073 DBMET02785 0.11 0.058 DBMET02786 | DBMET01165 | |
| 0.06 | 0.028 | 0.077 | Autotaxin inhibitor | 0.077 0.019 DBMET02785 0.056 0.032 DBMET02786 | DBMET02785 | |
| 0.088 | 0.056 | 0.115 | Androgen antagonist | 0.078 0.067 DBMET02785 0.115 0.036 DBMET02786 | DBMET02786 | |
| 0.039 | 0.008 | 0.051 | Prostaglandin E2 agonist | 0.051 0.005 DBMET02785 0.033 0.009 DBMET02786 | DBMET02785 | |
| 0.035 | 0.005 | 0.047 | Free fatty acid receptor 1 agonist | 0.047 0.005 DBMET02785 0.025 0.008 DBMET02786 | DBMET02785 | |
| 0.048 | 0.019 | 0.048 | Acetyl-CoA transferase 1 inhibitor | 0.042 0.027 DBMET02785 0.042 0.027 DBMET02786 | ||
| 0.046 | 0.018 | 0.048 | Retinoic acid alpha receptor agonist | 0.044 0.019 DBMET02785 0.048 0.016 DBMET02786 | DBMET02786 | |
| 0.076 | 0.047 | 0.097 | Cathepsin G inhibitor | 0.097 0.034 DBMET02785 0.066 0.058 DBMET02786 | DBMET02785 | |
| 0.047 | 0.019 | 0.047 | G protein-coupled receptor agonist | 0.047 0.02 DBMET02785 | ||
| 0.092 | 0.065 | 0.113 | Prolactin inhibitor | 0.113 0.043 DBMET02785 0.111 0.045 DBMET02786 | DBMET02785 | |
| 0.065 | 0.039 | 0.065 | Calcium channel P-type blocker | |||
| 0.037 | 0.011 | 0.062 | Elastase 2B inhibitor | 0.062 0.003 DBMET01165 0.04 0.009 DBMET02785 0.034 0.014 DBMET02786 | DBMET01165 | |
| 0.037 | 0.011 | 0.062 | Elastase 3A inhibitor | 0.062 0.003 DBMET01165 0.04 0.009 DBMET02785 0.034 0.014 DBMET02786 | DBMET01165 | |
| 0.037 | 0.011 | 0.062 | Elastase 3B inhibitor | 0.062 0.003 DBMET01165 0.04 0.009 DBMET02785 0.034 0.014 DBMET02786 | DBMET01165 | |
| 0.047 | 0.022 | 0.064 | Liver X receptor alpha agonist | 0.064 0.011 DBMET02785 0.046 0.023 DBMET02786 | DBMET02785 | |
| 0.089 | 0.065 | 0.109 | Alcohol dehydrogenase inhibitor | 0.109 0.044 DBMET02786 | DBMET02786 | |
| 0.055 | 0.031 | 0.059 | Vanilloid 2 antagonist | 0.049 0.045 DBMET02785 0.059 0.024 DBMET02786 | DBMET02786 | |
| 0.076 | 0.052 | 0.076 | GABA aminotransferase inhibitor | 0.075 0.054 DBMET01165 0.07 0.062 DBMET02786 | ||
| 0.04 | 0.018 | 0.056 | Squalene synthetase inhibitor | 0.056 0.013 DBMET01165 0.036 0.02 DBMET02785 0.035 0.02 DBMET02786 | DBMET01165 | |
| 0.056 | 0.034 | 0.064 | Elastase inhibitor | 0.064 0.027 DBMET01165 0.056 0.033 DBMET02785 0.049 0.044 DBMET02786 | DBMET01165 | |
| 0.076 | 0.055 | 0.098 | Estrogen receptor alpha antagonist | 0.098 0.028 DBMET02786 | DBMET02786 | |
| 0.03 | 0.009 | 0.035 | Leukotriene B4 receptor 2 antagonist | 0.028 0.01 DBMET01165 0.031 0.008 DBMET02785 0.035 0.007 DBMET02786 | DBMET02786 | |
| 0.026 | 0.005 | 0.03 | Estrogen-related receptor gamma agonist | 0.03 0.004 DBMET02786 | DBMET02786 | |
| 0.069 | 0.048 | 0.085 | Phenylalanine 4-hydroxylase inhibitor | 0.085 0.034 DBMET02786 | DBMET02786 | |
| 0.031 | 0.011 | 0.031 | Retinoid X gamma receptor antagonist | 0.028 0.016 DBMET02785 0.03 0.013 DBMET02786 | ||
| 0.023 | 0.003 | 0.023 | Thromboxane agonist | 0.022 0.004 DBMET02785 0.019 0.004 DBMET02786 | ||
| 0.075 | 0.055 | 0.105 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.098 0.038 DBMET02785 0.105 0.035 DBMET02786 | DBMET02786 | |
| 0.051 | 0.032 | 0.062 | Plasminogen activator inhibitor antagonist | 0.047 0.037 DBMET02785 0.062 0.023 DBMET02786 | DBMET02786 | |
| 0.062 | 0.043 | 0.071 | Beta 2 adrenoreceptor agonist | 0.071 0.018 DBMET02785 0.071 0.018 DBMET02786 | DBMET02786 | |
| 0.041 | 0.023 | 0.048 | Glutamate (mGluR group II) antagonist | 0.048 0.018 DBMET02785 0.034 0.033 DBMET02786 | DBMET02785 | |
| 0.087 | 0.07 | 0.106 | Glutamate release inhibitor | 0.092 0.056 DBMET01165 0.106 0.035 DBMET02785 0.093 0.056 DBMET02786 | DBMET02785 | |
| 0.046 | 0.03 | 0.053 | Beta adrenoreceptor agonist | 0.052 0.014 DBMET02785 0.053 0.013 DBMET02786 | DBMET02786 | |
| 0.022 | 0.007 | 0.043 | Thyroid hormone alpha antagonist | 0.017 0.009 DBMET02785 0.043 0.004 DBMET02786 | DBMET02786 | |
| 0.03 | 0.015 | 0.044 | Prostaglandin EP4 antagonist | 0.044 0.009 DBMET02785 | DBMET02785 | |
| 0.131 | 0.116 | 0.137 | Heat shock protein 70 antagonist | 0.137 0.086 DBMET02786 | DBMET02786 | |
| 0.023 | 0.009 | 0.023 | Retinoic acid beta receptor agonist | 0.022 0.011 DBMET02785 0.022 0.01 DBMET02786 | ||
| 0.052 | 0.039 | 0.085 | Alpha-mannosidase inhibitor | 0.085 0.009 DBMET01165 0.061 0.026 DBMET02785 0.058 0.029 DBMET02786 | DBMET01165 | |
| 0.042 | 0.028 | 0.042 | Kainate receptor agonist | 0.04 0.031 DBMET02786 | ||
| 0.039 | 0.025 | 0.039 | Vanilloid 3 antagonist | 0.039 0.025 DBMET02786 | ||
| 0.055 | 0.041 | 0.055 | Argininosuccinate synthase inhibitor | 0.052 0.045 DBMET02786 | ||
| 0.032 | 0.019 | 0.035 | Prostaglandin D2 agonist | 0.035 0.016 DBMET02785 0.031 0.02 DBMET02786 | DBMET02785 | |
| 0.039 | 0.025 | 0.041 | Farnesoid X receptor agonist | 0.041 0.022 DBMET02785 0.034 0.031 DBMET02786 | DBMET02785 | |
| 0.072 | 0.058 | 0.107 | Na+ K+ transporting ATPase inhibitor | 0.107 0.025 DBMET01165 0.087 0.044 DBMET02785 0.085 0.046 DBMET02786 | DBMET01165 | |
| 0.024 | 0.011 | 0.024 | Retinoid X beta receptor agonist | 0.024 0.012 DBMET02785 0.019 0.017 DBMET02786 | ||
| 0.035 | 0.022 | 0.035 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.026 DBMET02785 0.033 0.028 DBMET02786 | ||
| 0.11 | 0.098 | 0.124 | Antibacterial (Helicobacter pylori) | 0.117 0.086 DBMET02785 0.124 0.075 DBMET02786 | DBMET02786 | |
| 0.167 | 0.154 | 0.345 | Peptidyltransferase inhibitor | 0.345 0.013 DBMET01165 0.183 0.123 DBMET02786 | DBMET01165 | |
| 0.125 | 0.113 | 0.125 | Pregnane X receptor agonist | |||
| 0.076 | 0.064 | 0.111 | Adrenaline agonist | 0.104 0.034 DBMET02785 0.111 0.03 DBMET02786 | DBMET02786 | |
| 0.041 | 0.03 | 0.046 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.046 0.02 DBMET02786 | DBMET02786 | |
| 0.043 | 0.032 | 0.043 | Geranyltranstransferase inhibitor | |||
| 0.025 | 0.014 | 0.025 | Retinoid X gamma receptor agonist | 0.023 0.016 DBMET02785 | ||
| 0.029 | 0.019 | 0.054 | Liver X receptor beta antagonist | 0.054 0.007 DBMET02785 0.031 0.019 DBMET02786 | DBMET02785 | |
| 0.026 | 0.016 | 0.026 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.049 | 0.04 | 0.099 | Glucose-6-phosphate translocase inhibitor | 0.099 0.006 DBMET01165 0.055 0.029 DBMET02785 0.06 0.024 DBMET02786 | DBMET01165 | |
| 0.037 | 0.028 | 0.04 | Glutamate (mGluR8) agonist | 0.04 0.023 DBMET02786 | DBMET02786 | |
| 0.033 | 0.024 | 0.033 | Carnitine palmitoyltransferase inhibitor | |||
| 0.039 | 0.03 | 0.039 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.022 | 0.014 | 0.025 | Vitamin D receptor antagonist | 0.025 0.01 DBMET01165 0.023 0.013 DBMET02785 0.022 0.015 DBMET02786 | DBMET01165 | |
| 0.044 | 0.036 | 0.044 | Parathyroid hormone antagonist | |||
| 0.035 | 0.028 | 0.035 | Glutamate (mGluR3) antagonist | 0.033 0.032 DBMET02785 | ||
| 0.033 | 0.026 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.03 DBMET02786 | ||
| 0.057 | 0.05 | 0.064 | Transcription factor AP-1 inhibitor | 0.064 0.039 DBMET01165 0.063 0.039 DBMET02786 | DBMET01165 | |
| 0.023 | 0.016 | 0.023 | Retinoic acid receptor agonist | 0.023 0.016 DBMET02786 | ||
| 0.036 | 0.03 | 0.049 | Urate transporter 1 inhibitor | 0.049 0.019 DBMET02786 | DBMET02786 | |
| 0.018 | 0.011 | 0.021 | Ileal bile acid transport inhibitor | 0.021 0.008 DBMET01165 0.02 0.009 DBMET02785 0.02 0.009 DBMET02786 | DBMET01165 | |
| 0.02 | 0.014 | 0.021 | Retinoic acid alpha receptor antagonist | 0.021 0.013 DBMET02786 | DBMET02786 | |
| 0.12 | 0.115 | 0.334 | NOS3 expression enhancer | 0.334 0.013 DBMET01165 0.121 0.113 DBMET02786 | DBMET01165 | |
| 0.093 | 0.089 | 0.104 | GABA C receptor antagonist | 0.104 0.072 DBMET02786 | DBMET02786 | |
| 0.047 | 0.042 | 0.047 | Ornithine carbamoyltransferase inhibitor | |||
| 0.024 | 0.02 | 0.033 | Vanilloid 2 agonist | 0.033 0.007 DBMET01165 0.024 0.021 DBMET02785 0.027 0.014 DBMET02786 | DBMET01165 | |
| 0.021 | 0.018 | 0.027 | Beta 1 adrenoreceptor agonist | 0.026 0.011 DBMET02785 0.027 0.01 DBMET02786 | DBMET02786 | |
| 0.036 | 0.033 | 0.036 | Membrane dipeptidase inhibitor | |||
| 0.117 | 0.113 | 0.13 | Acetylcholine M1 receptor antagonist | 0.13 0.096 DBMET02786 | DBMET02786 | |
| 0.031 | 0.028 | 0.031 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.018 | 0.015 | 0.018 | 5-Alpha-reductase 2 inhibitor | |||
| 0.021 | 0.018 | 0.021 | Prostaglandin D2 antagonist | |||
| 0.071 | 0.068 | 0.071 | Histamine H1 receptor antagonist | |||
| 0.015 | 0.012 | 0.015 | Prostacyclin agonist | |||
| 0.037 | 0.035 | 0.037 | VCAM-1 antagonist | |||
| 0.021 | 0.019 | 0.022 | Retinoic acid gamma receptor agonist | 0.022 0.016 DBMET02786 | DBMET02786 | |
| 0.037 | 0.035 | 0.037 | VCAM antagonist | |||
| 0.097 | 0.095 | 0.114 | Acetylcholine release stimulant | 0.114 0.059 DBMET01165 | DBMET01165 | |
| 0.033 | 0.031 | 0.045 | Ceramide glucosyltransferase inhibitor | 0.036 0.025 DBMET01165 0.045 0.011 DBMET02785 | DBMET02785 | |
| 0.017 | 0.015 | 0.017 | Retinoic acid receptor antagonist | 0.017 0.014 DBMET02786 | ||
| 0.071 | 0.07 | 0.091 | Carbonic anhydrase VI inhibitor | 0.091 0.045 DBMET02785 | DBMET02785 | |
| 0.084 | 0.083 | 0.089 | Interleukin 1 beta converting enzyme inhibitor | 0.085 0.081 DBMET02785 0.089 0.074 DBMET02786 | DBMET02786 | |
| 0.02 | 0.019 | 0.02 | Glutamate (mGluR1a) agonist | |||
| 0.008 | 0.008 | 0.015 | Thyroid hormone beta agonist | 0.015 0.004 DBMET02786 | DBMET02786 | |
| 0.018 | 0.018 | 0.019 | Caspase 8 inhibitor | 0.019 0.016 DBMET02786 | DBMET02786 | |
| 0.025 | 0.026 | 0.032 | Glucagon receptor antagonist | 0.032 0.018 DBMET02785 | DBMET02785 | |
| 0.055 | 0.056 | 0.059 | Ryanodine receptor antagonist | 0.059 0.041 DBMET02786 | DBMET02786 | |
| 0.064 | 0.065 | 0.095 | Carbonic anhydrase XIII inhibitor | 0.095 0.041 DBMET02785 0.08 0.05 DBMET02786 | DBMET02785 | |
| 0.056 | 0.058 | 0.057 | Caspase 9 inhibitor | 0.057 0.053 DBMET02785 | DBMET02785 | |
| 0.051 | 0.054 | 0.053 | Acetyl-CoA transferase 2 inhibitor | 0.053 0.047 DBMET02786 | DBMET02786 | |
| 0.025 | 0.029 | 0.029 | Glutamate (mGluR2) antagonist | 0.029 0.021 DBMET02785 | DBMET02785 | |
| 0.046 | 0.05 | 0.067 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.067 0.024 DBMET02786 | DBMET02786 | |
| 0.086 | 0.091 | 0.119 | Estrogen receptor beta antagonist | 0.119 0.033 DBMET02786 | DBMET02786 | |
| 0.095 | 0.1 | 0.108 | Caspase 3 inhibitor | 0.108 0.079 DBMET02786 | DBMET02786 | |
| 0.094 | 0.099 | 0.168 | Beta amyloid protein antagonist | 0.168 0.029 DBMET01165 0.111 0.077 DBMET02786 | DBMET01165 | |
| 0.028 | 0.033 | 0.039 | Liver X receptor beta agonist | 0.039 0.016 DBMET02785 | DBMET02785 | |
| 0.029 | 0.035 | 0.034 | Melatonin receptor 1A agonist | 0.034 0.022 DBMET02785 | DBMET02785 | |
| 0.085 | 0.092 | 0.116 | Phosphodiesterase 6D inhibitor | 0.116 0.029 DBMET01165 | DBMET01165 | |
| 0.112 | 0.12 | 0.257 | Thrombolytic | 0.257 0.032 DBMET01165 0.12 0.11 DBMET02785 0.125 0.105 DBMET02786 | DBMET01165 | |
| 0.022 | 0.03 | 0.093 | Sodium/glucose cotransporter 2 inhibitor | 0.093 0.003 DBMET01165 0.028 0.016 DBMET02785 | DBMET01165 | |
| 0.013 | 0.021 | 0.02 | Thyroid hormone alpha agonist | 0.02 0.007 DBMET02786 | DBMET02786 | |
| 0.053 | 0.061 | 0.057 | Prostaglandin F2 alpha antagonist | 0.057 0.053 DBMET02786 | DBMET02786 | |
| 0.037 | 0.045 | 0.077 | Mannosidase inhibitor | 0.077 0.009 DBMET01165 0.047 0.029 DBMET02785 0.042 0.036 DBMET02786 | DBMET01165 | |
| 0.048 | 0.057 | 0.059 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.059 0.041 DBMET02786 | DBMET02786 | |
| 0.024 | 0.033 | 0.031 | Prostacyclin antagonist | 0.031 0.024 DBMET02785 | DBMET02785 | |
| 0.062 | 0.073 | 0.068 | CDC25A inhibitor | 0.068 0.061 DBMET02786 | DBMET02786 | |
| 0.021 | 0.033 | 0.079 | Sodium/glucose cotransporter inhibitor | 0.079 0.004 DBMET01165 0.028 0.014 DBMET02785 | DBMET01165 | |
| 0.035 | 0.047 | 0.05 | Adenosine deaminase inhibitor | 0.05 0.03 DBMET02785 | DBMET02785 | |
| 0.048 | 0.063 | 0.341 | Selectin antagonist | 0.341 0.004 DBMET01165 0.071 0.041 DBMET02785 | DBMET01165 | |
| 0.012 | 0.027 | 0.017 | Telomerase stimulant | 0.017 0.012 DBMET01165 | DBMET01165 | |
| 0.027 | 0.042 | 0.03 | Estrogen-related receptor beta antagonist | 0.03 0.028 DBMET02786 | DBMET02786 | |
| 0.045 | 0.06 | 0.09 | Heparanase inhibitor | 0.09 0.005 DBMET01165 | DBMET01165 | |
| 0.055 | 0.071 | 0.094 | Elastase 1 inhibitor | 0.094 0.024 DBMET01165 0.061 0.06 DBMET02785 | DBMET01165 | |
| 0.037 | 0.053 | 0.064 | Prostaglandin E2 antagonist | 0.064 0.026 DBMET02785 | DBMET02785 | |
| 0.119 | 0.136 | 0.241 | Amyloid beta aggregation inhibitor | 0.241 0.061 DBMET02786 | DBMET02786 | |
| 0.034 | 0.05 | 0.075 | Estrogen agonist | 0.052 0.034 DBMET01165 0.075 0.024 DBMET02786 | DBMET02786 | |
| 0.088 | 0.105 | 0.215 | Alkylator | 0.215 0.022 DBMET01165 0.131 0.058 DBMET02785 0.105 0.083 DBMET02786 | DBMET01165 | |
| 0.015 | 0.035 | 0.02 | Elastase 2 inhibitor | 0.02 0.019 DBMET01165 | DBMET01165 | |
| 0.015 | 0.035 | 0.02 | Elastase 2A inhibitor | 0.02 0.019 DBMET01165 | DBMET01165 | |
| 0.05 | 0.072 | 0.066 | Lipocortins synthesis agonist | 0.066 0.026 DBMET01165 | DBMET01165 | |
| 0.034 | 0.056 | 0.048 | Ribonucleoside-diphosphate reductase inhibitor | 0.048 0.042 DBMET02786 | DBMET02786 | |
| 0.047 | 0.071 | 0.069 | Purinergic P2X1 antagonist | 0.069 0.032 DBMET02786 | DBMET02786 | |
| 0.046 | 0.071 | 0.079 | HIV-1 integrase (3'-Processing) inhibitor | 0.079 0.034 DBMET02786 | DBMET02786 | |
| 0.032 | 0.057 | 0.042 | Liver X receptor agonist | 0.042 0.033 DBMET02785 | DBMET02785 | |
| 0.034 | 0.058 | 0.048 | Ribonucleotide reductase inhibitor | 0.048 0.044 DBMET02786 | DBMET02786 | |
| 0.114 | 0.139 | 0.126 | GABA C receptor rho-2 antagonist | 0.126 0.114 DBMET02786 | DBMET02786 | |
| 0.103 | 0.129 | 0.246 | Cell wall synthesis inhibitor | 0.246 0.017 DBMET01165 0.115 0.108 DBMET02785 | DBMET01165 | |
| 0.042 | 0.069 | 0.053 | Sphingosine kinase 2 inhibitor | 0.053 0.042 DBMET02785 | DBMET02785 | |
| 0.046 | 0.075 | 0.055 | Sphingosine kinase inhibitor | 0.055 0.049 DBMET02785 | DBMET02785 | |
| 0.05 | 0.079 | 0.088 | Histidine decarboxylase inhibitor | 0.088 0.038 DBMET02785 0.088 0.038 DBMET02786 | DBMET02786 | |
| 0.141 | 0.17 | 0.18 | Cyclic AMP phosphodiesterase inhibitor | 0.18 0.111 DBMET01165 0.158 0.138 DBMET02786 | DBMET01165 | |
| 0.069 | 0.1 | 0.087 | Protease inhibitor | 0.087 0.078 DBMET02785 | DBMET02785 | |
| 0.032 | 0.063 | 0.056 | Microtubule stabilization | 0.056 0.02 DBMET01165 | DBMET01165 | |
| 0.028 | 0.062 | 0.039 | Phosphodiesterase 3B inhibitor | 0.039 0.038 DBMET02785 | DBMET02785 | |
| 0.071 | 0.105 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.072 DBMET02785 | DBMET02785 | |
| 0.018 | 0.056 | 0.031 | Liver X receptor alpha antagonist | 0.031 0.017 DBMET02785 | DBMET02785 | |
| 0.043 | 0.084 | 0.06 | Carbonic anhydrase V inhibitor | 0.06 0.054 DBMET02785 | DBMET02785 | |
| 0.099 | 0.14 | 0.113 | Neurotrophic factor | 0.113 0.108 DBMET02785 | DBMET02785 | |
| 0.116 | 0.158 | 0.146 | Interleukin antagonist | 0.146 0.121 DBMET02786 | DBMET02786 | |
| 0.011 | 0.053 | 0.02 | Corticosteroid-like | 0.02 0.017 DBMET01165 | DBMET01165 | |
| 0.03 | 0.073 | 0.059 | Carbonic anhydrase XIV inhibitor | 0.059 0.025 DBMET01165 | DBMET01165 | |
| 0.016 | 0.059 | 0.029 | Liver X receptor antagonist | 0.029 0.024 DBMET02785 | DBMET02785 | |
| 0.115 | 0.159 | 0.133 | CF transmembrane conductance regulator agonist | 0.133 0.11 DBMET02786 | DBMET02786 | |
| 0.029 | 0.073 | 0.05 | Carbonic anhydrase VB inhibitor | 0.05 0.045 DBMET02785 | DBMET02785 | |
| 0.012 | 0.061 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.005 DBMET01165 | DBMET01165 | |
| 0.05 | 0.108 | 0.069 | HIV-1 integrase inhibitor | 0.069 0.049 DBMET02786 | DBMET02786 | |
| 0.03 | 0.088 | 0.06 | Maillard reaction inhibitor | 0.06 0.034 DBMET02786 | DBMET02786 | |
| 0.017 | 0.075 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.022 DBMET01165 | DBMET01165 | |
| 0.032 | 0.092 | 0.058 | HIV-1 integrase (Strand Transfer) inhibitor | 0.058 0.043 DBMET02786 | DBMET02786 | |
| 0.066 | 0.126 | 0.083 | Thioredoxin inhibitor | 0.083 0.074 DBMET01165 | DBMET01165 | |
| 0.059 | 0.12 | 0.139 | Bronchodilator | 0.139 0.035 DBMET02785 0.104 0.06 DBMET02786 | DBMET02785 | |
| 0.1 | 0.165 | 0.144 | Growth hormone agonist | 0.144 0.092 DBMET02786 | DBMET02786 | |
| 0.026 | 0.097 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.05 0.023 DBMET01165 | DBMET01165 | |
| 0.025 | 0.105 | 0.09 | Protein 50S ribosomal subunit inhibitor | 0.09 0.016 DBMET01165 | DBMET01165 | |
| 0.047 | 0.13 | 0.082 | Potassium channel (Ca-activated) activator | 0.082 0.072 DBMET02786 | DBMET02786 | |
| 0.031 | 0.116 | 0.05 | Cytokine production stimulant | 0.05 0.028 DBMET01165 | DBMET01165 | |
| 0.018 | 0.103 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 DBMET01165 | DBMET01165 | |
| 0.042 | 0.132 | 0.069 | Potassium channel large-conductance Ca-activated activator | 0.069 0.045 DBMET02786 | DBMET02786 | |
| 0.137 | 0.229 | 0.183 | 12-Lipoxygenase inhibitor | 0.183 0.17 DBMET02786 | DBMET02786 | |
| 0.123 | 0.22 | 0.221 | DNA damaging | 0.221 0.099 DBMET01165 | DBMET01165 | |
| 0.089 | 0.185 | 0.167 | DNA repair enzyme inhibitor | 0.167 0.019 DBMET01165 | DBMET01165 | |
| 0.064 | 0.169 | 0.1 | Toll-Like receptor 3 antagonist | 0.1 0.051 DBMET02785 | DBMET02785 | |
| 0.056 | 0.162 | 0.12 | Chelator | 0.12 0.054 DBMET02786 | DBMET02786 | |
| 0.152 | 0.268 | 0.298 | Caspase 3 stimulant | 0.298 0.079 DBMET01165 0.189 0.187 DBMET02785 0.205 0.161 DBMET02786 | DBMET01165 | |
| 0.162 | 0.279 | 0.578 | Antibacterial | 0.578 0.023 DBMET01165 0.236 0.191 DBMET02786 | DBMET01165 | |
| 0.106 | 0.224 | 0.142 | CC chemokine 6 receptor antagonist | 0.142 0.036 DBMET01165 | DBMET01165 | |
| 0.071 | 0.192 | 0.189 | Cell adhesion inhibitor | 0.189 0.028 DBMET01165 | DBMET01165 | |
| 0.02 | 0.15 | 0.063 | Neuraminidase inhibitor | 0.063 0.039 DBMET01165 | DBMET01165 | |
| 0.023 | 0.16 | 0.162 | Antineoplastic antibiotic | 0.162 0.028 DBMET01165 | DBMET01165 | |
| 0.028 | 0.167 | 0.071 | Neuraminidase (influenza) inhibitor | 0.071 0.034 DBMET01165 | DBMET01165 | |
| 0.046 | 0.19 | 0.109 | Cell adhesion molecule inhibitor | 0.109 0.029 DBMET01165 | DBMET01165 | |
| 0.043 | 0.249 | 0.156 | Beta glucuronidase inhibitor | 0.156 0.022 DBMET01165 | DBMET01165 | |
| 0.025 | 0.232 | 0.093 | Topoisomerase II alpha inhibitor | 0.093 0.044 DBMET01165 | DBMET01165 | |
| 0.023 | 0.246 | 0.069 | Factor IXa inhibitor | 0.069 0.021 DBMET01165 | DBMET01165 | |
| 0.025 | 0.276 | 0.189 | Topoisomerase I inhibitor | 0.189 0.029 DBMET01165 | DBMET01165 | |
| 0.091 | 0.388 | 0.422 | Immunomodulator | 0.422 0.038 DBMET01165 | DBMET01165 | |
| 0.015 | 0.314 | 0.06 | Antibiotic Aminoglycoside-like | 0.06 0.009 DBMET01165 | DBMET01165 | |
| 0.032 | 0.343 | 0.123 | Multidrug resistance-associated protein 1 inhibitor | 0.123 0.045 DBMET01165 | DBMET01165 | |
| 0.007 | 0.343 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 DBMET01165 | DBMET01165 | |
| 0.05 | 0.438 | 0.286 | Alpha-glucosidase inhibitor | 0.286 0.167 DBMET01165 | DBMET01165 | |
| 0.018 | 0.441 | 0.111 | Topoisomerase II inhibitor | 0.111 0.075 DBMET01165 | DBMET01165 | |
| 0.027 | 0.463 | 0.145 | Anticoagulant | 0.145 0.085 DBMET01165 | DBMET01165 | |
| 0.03 | 0.564 | 0.303 | Tumour necrosis factor alpha release inhibitor | 0.303 0.052 DBMET01165 | DBMET01165 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |